期刊文献+

microRNA-10a对脓毒症小鼠脾脏CD4+CD25+Treg免疫功能的影响 被引量:14

The effects of miR-10a on the immune function of splenic CD4+ CD25+ Treg cells in septic mice
原文传递
导出
摘要 目的探讨脓毒症小鼠CD4+CD25+Treg(regulatory cell)细胞中microRNA-10a(miR-10a)表达规律及与细胞免疫功能的关系。方法采用清沽级雄性Balb/c小鼠建立稳定的小鼠盲肠结扎穿孔( cecal ligation and puncture, CLP )模型,分别于术后1、3、5、7d处死小鼠,无菌留取脾脏,免疫磁珠法分选CD4+T细胞与CD4+CD25+T细胞(CD4+CD25+Trego流式细胞术检测CD4+CD25+Treg胞内叉头蛋白翼状螺旋转录因子P3( Forkhead/winged helix transcription factor p3, Foxp3 ),CCK-8法检测脾效应T淋巴细胞增殖,实时定量PCR(Real—timePCR)检测Treg中miR-10a的基因表达水平。小鼠尾静脉注射慢病毒下调miR-10a,观察小鼠免疫功能。数据采用SPSS19.0统计软件进行数据处理,两组样本比较采用独立样本t检验,多组均数比较采用单因素方差分析(ANOVA)和Dunnett-t检验。结果正常组小鼠CD4+CD25+Treg细胞在CD4+T细胞中的比例为(7.34±1.2)%,造模后脓毒症小鼠脾脏CD4+CD25+Treg比例1、3、5、7d明显升高(P〈0.05o与假手术组相比,脓毒症小鼠Foxp3的平均荧光强度( mean fluorescence intensity, MFI )也明显高于假手术组(P〈0.05)。Real-imePCR检测CD4+CD25+reg中miR-10a的表达。结果发现假手术组小鼠与正常组小鼠相比差异无统计学意义(P〉0.05)。毒症小鼠Treg中miR-0a表达较假手术组升高(P〈0.05o脓毒症鼠尾静脉注射携带miR-10a抑制序列的慢病毒后,CD4+CD25+Treg/CD4+T比例明显升高(P〈0.05),且Foxp3的平均荧光强度也明显增强(P〈0.05),CD4+T细胞的增殖能力相应减弱(P〈0.05)。结论在脓毒症致病过程Treg中miR-10a表达上调,抑制miR-10a水平能够显著提高Treg的比例和促进免疫抑制功能。鉴于CD4+CD25+Treg在脓毒症免疫功能紊乱中的重要作用,miR-10a可能是脓毒症免疫调理治疗的有效靶点。 Objective To investigate the role of miR-10a in CD4+CD25+Treg-mediated immunosuppression during sepsis and its potential role in immunotherapy for sepsis. Methods Sepsis mouse model was established by cecal ligation and puncture(CLP). Balb/c mice of clean grade were sacrificed 1, 3, 5, and 7 days after operation. Blood as well as spleen samples were harvested at given intervals. The splenic CD4+CD25+Treg cells and CD4+T cells were isolated by MACS microbeads. Cells were cultured, and phenotypes were analyzed by flow cytometry. The miR-10a expressed in Treg ceils were detected by Real-time PCR. After administration of LV-mmu-miR-10a-5p-inhibition, the immunosuppressive function have been detected. Statistical analyses were performed using one-way analysis of variance (SPSS19.0, Chicago, USA) test followed by Dunnett-t test to compare among three or more groups or by Student's t-test to compare between two groups. Results The percentages of splenic Tregs (CD4+CD25+/CD4+T) was (7.34±1.2)% in normal group, and the increase in percentage of Tregs in spleen has been observed in septic mice (P〈0.05). The mean fluorescence intensity (MFI) of Foxp3+Treg was increased in septic mice compared with sham group (P〈0.05). The expression of miR- 10a was significantly elevated on CLP 1-7 day (P〈0.05). After down-regulation of miR-10a in septic mice, the percentages of Tregs (CD4+CD25+/CD4+T) was significantly increased in septic mice (P〈0.05), the MFI of Foxp3+Treg was increased in septic mice compared with control group (P〈0.05). The CD4+T cell proliferative activity in CLP-induced mice was significantly suppressed on CLP 3 day compared with sham group (P〈0.05).After down-regulation of miR-10a in septic mice, the CD4+T cell proliferative activity was significantly suppressed compared with control group (P〈0.05). Conclusions Treg plays a critical role in immunosuppression in septic mice. Inhibition of miR-10a in vivo could enhence immunesuppression of CD4+CD25+Treg. Therefore miR-10a may participate in the regulation of CD4+CD25+Treg inununosuppression in sepsis and become the target for immunotherapy.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2018年第2期152-158,共7页 Chinese Journal of Emergency Medicine
基金 国家自然科学基金(81401621、81571937) 浙江省自然科学基金(LY13H150004、LY13H150006、LY15H150006) 浙江省中医药优秀青年人才基金(2013ZQ023) 温州市科技计划项目(Y20150033)
关键词 调节性T细胞 脓毒症 microRNA-10a 叉头蛋白翼状螺旋转录因子P3 免疫功能 效应T细胞 细胞增殖 平均荧光强度 Regulatory T cells Sepsis MicroRNA-10a Forkhead/winged helix transcription factor p3 Immune function Effector T cell Proliferative activity Mean fluorescence intensity
  • 相关文献

参考文献3

二级参考文献25

  • 1Vincent JL, Opal SM, Marshall JC, et al. Sepsis definitions: time for change [ J]. The Lancet, 2013, 381 (9868) : 774-775. DOI: 10. 1016/S0140-6736 (12) 61815-7.
  • 2Chen K, Zhou QX, Shan HW, et al. Prognostic value of CD4 ( + ) CD25 ( + ) Tregs as a valuable biomarker for patients with sepsis in ICU. [J]. World J Emerg Med, 2015, 6 (1) : 40-43. DOI: 10. 5847/wjem. j. 1920-8642. 2015. 01. 007.
  • 3Machado FR, Mazza BF. Improving mortality in sepsis: analysis of clinical trials [J]. Shock, 2010, 34 (Suppl 1): 54-58. DOI: 10. 1097/SHK. 0bO13e3181eTe8b4.
  • 4Wu ZS, Yao YM, Hong GL, et al. Role of mitofusin-2 in high mobility group box-1 protein-mediated apoptosis of T cells in vitro [J]. Cell Physiol Biochem, 2014, 33 (3) : 769-783. DOI: 10. 1159/000358651.
  • 5Ammon HP, Wahl MA. Pharmacology of Curcuma longa [ J ]. Planta Med, 1991, 57 (1): 1-7. DOI: 10. 1055/s-2006- 960004.
  • 6Treves R, Maheu E, Dreiser RL. Therapeutic trials in digital osteoarthritis. A critical review [J]. Revuedu Rhumatisme, 1995, 62 (6 Suppl 1) : 33S-41S. DOI: 10. 1053/joea. 2000. 0339.
  • 7Habtemariam S. Antiinflammatory activity of the antirheumatic herbal drug, gravel root ( Eupatorium purpureum ) : further biological activities and constituents [ J]. Phy Res: PTR, 2001, 15 (8): 687-690. DOI: 10. 1002/ptr. 887.
  • 8Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance [J]. J Clin Invest, 2006, 116 (7): 1793-1801. DOI: 10. 1172/JCI29069.
  • 9Gescher A. Polyphenolic phytochemicals versus non-steroidal anti- inflammatory drugs which are better cancer chemopreventive agents [J]. J Chemother, 2004, Suppl4: 345.
  • 10Siddiqui AM, Cui X, Wu R, et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up- regulation of peroxisome proliferator-activatedreceptor-gamma [J]. Critical Care Medicine, 2006, 34 (7) : 1874-1882. DOI: 10. 1097/01. CCM. 0000221921. 71300.

共引文献19

同被引文献83

引证文献14

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部